Catalog No.
CS565136
Species reactivity
SARS-CoV-2(2019-nCoV)
Applications
Research Grade Biosimilar
Host species
Human
Isotype
IgG1, kappa
Expression system
Mammalian Cells
Clonality
Monoclonal
Target
Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD
Concentration 1mg/mlEndotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G, purified from cell culture supernatant.
Accession
P0DTC2-2
Form
Liquid
Storage buffer
0.01M PBS,pH7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -774°C.
Alternate Names
BI767551,BI-767551,DZIF-10c,EX14870,EX-14870CAS:2550869-33-3
Background Lomtegovimab (BI 767551) is a human anti-SARS-COV-2 spike glycoprotein monoclonal antibody. Lomtegovimab binds and neutralizes SARS-CoV-2. Lomtegovimab shows antiviral efficacy. Lomtegovimab has the potential for the research of COVID-19.Note
For research use only. Not for use in clinical or therapeutic applications.
...